Moreover, we have shown that pre-treating the stroma of fully immunocompetent mice with hemin, a well-known inducer of HO-1, prior to TRAMP-C1 tumor challenge, translates to a significant increase in tumor latency and a significant decrease in the initial tumor growth rate [34]. This evidence concerns the gene HMOX1 and neoplasm.